Tiedemann Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,824
Closed -$413K 281
2022
Q1
$413K Buy
1,824
+14
+0.8% +$3.29K 0.02% 204
2021
Q4
$489K Hold
1,810
0.02% 190
2021
Q3
$438K Sell
1,810
-14
-0.8% -$3.53K 0.02% 204
2021
Q2
$432K Sell
1,824
-22
-1% -$5.01K 0.02% 247
2021
Q1
$404K Buy
1,846
+280
+18% +$56.2K 0.02% 235
2020
Q4
$274K Buy
1,566
+73
+5% +$12.6K 0.01% 267
2020
Q3
$242K Hold
1,493
0.01% 283
2020
Q2
$212K Buy
+1,493
New +$207K 0.01% 276
2020
Q1
Sell
-1,596
Closed -$231K 309
2019
Q4
$231K Buy
+1,596
New +$230K 0.01% 274

Other funds holding LH

Tiedemann Advisors's LH Position: Q2 2022 in Review

Tiedemann Advisors sold out of Labcorp (LH) in Q2 2022, closing a stake of 1,824 shares — an estimated $413K sold.

Tiedemann Advisors first reported a position in LH in Q4 2019 and held it in 9 quarters. The position peaked at $489K in Q4 2021. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • Tiedemann Advisors reported no remaining Labcorp position as of Q2 2022 after selling out during the quarter.
  • Tiedemann Advisors sold 1,824 Labcorp shares in Q2 2022, an estimated $413K.
  • Tiedemann Advisors first reported a position in Labcorp in Q4 2019 and held it in 9 quarters.
  • Tiedemann Advisors's Labcorp position peaked at $489K in Q4 2021.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on Tiedemann Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.